The significance of ultra-low EGFR T790M mutations on EGFR-TKI efficacy in patients with NSCLC -the WJOG13119L study

被引：0

作者：

Masuda, Takeshi ^{[1
]}

Miura, Satoru ^{[2
]}

Koso, Hidenori ^{[3
]}

Yanagihara, Kazuhiro ^{[4
]}

Okamoto, Tatsuro ^{[5
]}

Shoda, Hiroyasu ^{[6
]}

Shimizu, Junichi ^{[7
]}

Kanaji, Nobuhiro ^{[8
]}

Hara, Satoshi ^{[9
]}

Sakata, Shinya ^{[10
]}

Tokito, Takaaki ^{[11
]}

Kashiwabara, Kosuke ^{[12
]}

Nishikawa, Kazuo ^{[13
]}

Watanabe, Hiroshi ^{[14
]}

Maeno, Ken ^{[15
]}

Suzuki, Shigeki ^{[16
]}

Hayakawa, Daisuke ^{[17
]}

Yamamoto, Nobuyuki ^{[18
]}

Nakagawa, Kazuhiko ^{[19
]}

Noboru, Hattori ^{[1
]}

机构：

[1] Hiroshima Univ Hosp, Dept Resp Med, Hiroshima, Japan

[2] Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan

[3] Natl Hosp Org, Oita Med Ctr, Dept Surg, Oita, Japan

[4] Kansai Elect Power Hosp, Dept Med Oncol, Osaka, Japan

[5] Natl Hosp Org Kyushu Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan

[6] Hiroshima City Hiroshima Citizens Hosp, Dept Resp Med, Hiroshima, Japan

[7] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan

[8] Kagawa Univ, Dept Internal Med, Div Hematol Rheumatol & Resp Med, Fac Med, Takamatsu, Kagawa, Japan

[9] Itami City Hosp, Dept Resp Med, Itami, Hyogo, Japan

[10] Kumamoto Univ Hosp, Dept Resp Med, Kumamoto, Japan

[11] Kurume Univ, Div Respirol Neurol & Rheumatol, Dept Internal Med, Sch Med, Kurume, Fukuoka, Japan

[12] Kumamoto Reg Med Ctr, Dept Resp Med, Kumamoto, Japan

[13] Oita Univ, Fac Med, Dept Med Oncol & Hematol, Oita, Japan

[14] Saka Gen Hosp, Dept Resp Med, Shiogama, Japan

[15] Nagoya City Univ, Dept Resp Med Allergy & Clin Immunol, Grad Sch Med Sci, Nagoya, Aichi, Japan

[16] Sagamihara Kyodo Hosp, Dept Gen Thorac Surg, Sagamihara, Kanagawa, Japan

[17] Juntendo Univ, Fac Med, Dept Resp Med, Tokyo, Japan

[18] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan

[19] Kindai Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka, Japan

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷

关键词：

D O I：

10.1016/j.annonc.2022.05.028

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O6-3

引用

页码：S470 / S471

页数：2

共 50 条

[31] T790M突变与EGFR-TKI耐药后治疗策略
王迪
甄春英
刘宝刚
现代肿瘤医学, 2015, 23 (19) : 2871 - 2874
[32] Association Between EGFR T790M Status and Progression Patterns During Initial EGFR-TKI Treatment in Patients Harboring EGFR Mutation
Oya, Yuko
Yoshida, Tatsuya
Kuroda, Hiroaki
Shimizu, Junichi
Horio, Yoshitsugu
Sakao, Yukinori
Inaba, Yoshitaka
Hida, Toyoaki
Yatabe, Yasushi
CLINICAL LUNG CANCER, 2017, 18 (06) : 698 - +
[33] Efficacy of YK-029A, a novel EGFR TKI, in advanced NSCLC patients with acquired T790M mutation
Wan, Rui
Chau, Yi Fung
Zhao, Jun
Liu, Zhe
Zhao, Mingfang
Zhao, Yanqiu
Dai, Xiumei
Pan, Yueyin
Zhang, Zhihong
Yao, Yu
Yang, Kunyu
Wu, Lin
Xie, Yanyan
Chen, Bi
Yang, Yixuan
Guo, Yongqi
Wang, Jie
Duan, Jianchun
CANCER RESEARCH, 2024, 84 (07)
[34] Machine learning-based radiomics strategy for prediction of acquired EGFR T790M mutation following treatment with EGFR-TKI in NSCLC
Lu, Jiameng
Ji, Xiaoqing
Liu, Xinyi
Jiang, Yunxiu
Li, Gang
Fang, Ping
Li, Wei
Zuo, Anli
Guo, Zihan
Yang, Shuran
Ji, Yanbo
Lu, Degan
SCIENTIFIC REPORTS, 2024, 14 (01)
[35] Detection of T790M mutation in EGFR gene, an EGFR-TKI resistant mutation, in tumor samples unexposed to EGFR TKIs
Koba, Hayato
Kimura, Hideharu
Nishikawa, Shingo
Yoneda, Taro
Sone, Takashi
Kasahara, Kazuo
CANCER RESEARCH, 2016, 76
[36] Machine learning-based radiomics strategy for prediction of acquired EGFR T790M mutation following treatment with EGFR-TKI in NSCLC
Jiameng Lu
Xiaoqing Ji
Xinyi Liu
Yunxiu Jiang
Gang Li
Ping Fang
Wei Li
Anli Zuo
Zihan Guo
Shuran Yang
Yanbo Ji
Degan Lu
Scientific Reports, 14
[37] EGFR T790M Mutation may not be Generated through Selection by EGFR-TKI from Randomly Occurring Mutations in Vitro Using ENU
Kobayashi, Y.
Mitsudomi, T.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S722 - S722
[38] A phase II study to assess the efficacy of osimertinib in patients with EGFR MT(+)T790M(-) NSCLC
Hayakawa, Daisuke
Takeda, Masayuki
Shimokawa, Mototsugu
Nakamura, Atsushi
Nosaki, Kaname
Watanabe, Yasutaka
Kato, Terufumi
Tanaka, Hiroshi
Takahashi, Toshiaki
Oki, Masahide
Tachihara, Motoko
Fujimoto, Daichi
Yamaguchi, Kakuhiro
Hayashi, Hidetoshi
Yamamoto, Shoichiro
Iwama, Eiji
Azuma, Koichi
Yamamoto, Nobuyuki
Nakagawa, Kazuhiko
ANNALS OF ONCOLOGY, 2023, 34 : S1387 - S1387
[39] The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma
Zhang, Qiuyi
Ke, Ee
Niu, Feiyu
Deng, Wei
Chen, Zhihong
Xu, Chongrui
Zhang, Xuchao
Zhao, Ning
Su, Jian
Yang, Jinji
Yan, Honghong
Wu, Yilong
Zhou, Qing
ONCOTARGET, 2017, 8 (03) : 4994 - 5002
[40] Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC
Tung, Pi-Hung
Chiu, Tzu-Hsuan
Huang, Allen Chung-Cheng
Ju, Jia-Shiuan
Huang, Chi-Hsien
Wang, Chin-Chou
Ko, How-Wen
Chung, Fu-Tsai
Hsu, Ping-Chih
Fang, Yueh-Fu
Guo, Yi-Ke
Kuo, Chih-Hsi Scott
Yang, Cheng-Ta
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16

← 1 2 3 4 5 →